Stocktoria
Black Hawk Acquisition Corp BKHA
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2024-03-21
Black Hawk Acquisition Corp financials (annual)
Bars are annual figures from 2024 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 |
|---|---|---|
| Operating income | -$915,510 | -$576,076 |
| Interest expense | $15,454 | — |
| Net income | $1.3M | $1.9M |
| Operating cash flow | -$650,321 | -$553,665 |
| Cash & equivalents | $0 | $0 |
| Total assets | $23.9M | $72.1M |
| Total liabilities | $3.9M | $2.5M |
| Shareholders' equity | -$3.8M | -$2.2M |
Growth · year-over-year
| Metric | FY2025 | FY2024 |
|---|---|---|
| Net income growth | -30.6% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-11-30. Facts plus Stocktoria's own computed scores — not investment advice.